Skip to main content
Mobile menu expand icon MenuClose
  • About Gimv
  • Investment platforms
  • Anchor investments
  • Portfolio
  • Team
  • News
  • Investors
  • en
  • About Gimv
  • Investment platforms
  • Anchor investments
  • Portfolio
  • Team
  • News
  • Investors
  • Sustainability
  • Working at/with Gimv
  • Contact
Search results Search results Search results

Search results

1 - 870 of 953 results
EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide
Press release
See more info
Share price
Page
Share price
See more info
Solid growth performance in the first half of FY 2025
Press release
See more info
Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group
Press release
See more info
Elderd Land
Team member
See more info
Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA
Press release
See more info
Lisa Collet
Team member
See more info
Lorenz Weihe
Team member
See more info
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
Press release
See more info
Manfredi Agnello
Team member
See more info

Pagination

  • See more results
870 of 953 results
  • Navigation
    • About Gimv
    • Investment platforms
    • Anchor investments
    • Portfolio
    • Our team
    • Sustainability
    • News
    • Investors
    • Partnerships
    • Working at/with Gimv
    • Contact
  • Investment platforms
    • Consumer
    • Healthcare
    • Smart Industries
    • Sustainable Cities
  • Investors
    • Corporate Governance
    • Share information
    • Shareholder structure
    • Results and annual reports
    • Key financial information
    • Analyst coverage
    • Financial calender
    • Shareholder meetings
    • Dividend
    • Bonds
  • LinkedIn
  • Twitter
  • YouTube
  • en
© Gimv 2026
  • Disclaimer
  • Privacy Policy
Powered by Dropsolid